These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 17373058)

  • 1. Canada's 2003 renewed drug strategy--an evidence-based review.
    DeBeck K; Wood E; Montaner J; Kerr T
    HIV AIDS Policy Law Rev; 2006 Dec; 11(2-3):1, 5-12. PubMed ID: 17373058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Canada's new federal 'National Anti-Drug Strategy': an informal audit of reported funding allocation.
    Debeck K; Wood E; Montaner J; Kerr T
    Int J Drug Policy; 2009 Mar; 20(2):188-91. PubMed ID: 18571396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug policy in Canada--the way forward.
    Kerr T; O'Briain W
    Can HIV AIDS Policy Law Rev; 2002 Jul; 7(1):1, 27-32. PubMed ID: 14765475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Moral regulation and the presumption of guilt in Health Canada's medical cannabis policy and practice.
    Lucas P
    Int J Drug Policy; 2009 Jul; 20(4):296-303. PubMed ID: 19124233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Canada's international response to HIV during times of global transition: a qualitative inquiry.
    Nixon S
    Curr HIV Res; 2011 Apr; 9(3):194-201. PubMed ID: 21457132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. House of Commons committee releases report on Canada's drug strategy.
    Jürgens R
    Can HIV AIDS Policy Law Rev; 2002 Dec; 7(2-3):9-12. PubMed ID: 14719486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Developing Canada's research base for harm reduction and health equity approaches to HIV prevention and treatment.
    Shoveller J; DeBeck K; Montaner J
    Can J Public Health; 2010; 101(6):442-4. PubMed ID: 21370777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A critical public-health ethics analysis of Canada's international response to HIV.
    Nixon SA; Benatar SR
    Glob Public Health; 2011; 6(7):777-93. PubMed ID: 21390963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health Canada's use of its priority review process for new drugs: a cohort study.
    Lexchin J
    BMJ Open; 2015 May; 5(5):e006816. PubMed ID: 25967989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Canadian perspective on addiction treatment.
    El-Guebaly N
    Subst Abus; 2014; 35(3):298-303. PubMed ID: 24857633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Panel: emerging issues in Canada's drug policy--implications for HIV prevention and health promotion for people who use drugs.
    Strike C; Elliott R; Nolin C
    HIV AIDS Policy Law Rev; 2009 Dec; 14(2):93-8. PubMed ID: 20225528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perceptions of a drug prevention public service announcement campaign among street-involved youth in Vancouver, Canada: a qualitative study.
    Ti L; Fast D; Small W; Kerr T
    Harm Reduct J; 2017 Jan; 14(1):3. PubMed ID: 28086787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Canada's health system.
    Davies BJ
    Croat Med J; 1999 Jun; 40(2):280-6. PubMed ID: 10234072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Canada's new drug-impaired driving law: the need to consider other approaches.
    Solomon R; Chamberlain E
    Traffic Inj Prev; 2014; 15(7):685-93. PubMed ID: 24380375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How many HIV infections are prevented by Vancouver Canada's supervised injection facility?
    Pinkerton SD
    Int J Drug Policy; 2011 May; 22(3):179-83. PubMed ID: 21450450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defining harm reduction.
    Single E
    Drug Alcohol Rev; 1995; 14(3):287-90. PubMed ID: 16203323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assuring the affordability of Canada's health care system.
    Rowand RS; Scully HE
    Clin Invest Med; 1994 Aug; 17(4):328-33. PubMed ID: 7982296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A review of the efficacy and effectiveness of harm reduction strategies for alcohol, tobacco and illicit drugs.
    Ritter A; Cameron J
    Drug Alcohol Rev; 2006 Nov; 25(6):611-24. PubMed ID: 17132577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Canada's contribution to global research in cardiovascular diseases.
    Nguyen HV; de Oliveira C; Wijeysundera HC; Wong WW; Woo G; Grootendorst P; Liu PP; Krahn MD
    Can J Cardiol; 2013 Jun; 29(6):742-6. PubMed ID: 23219608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Putting children first: An opportunity for Canada's new government.
    MacLeod S
    Healthc Manage Forum; 2016 Mar; 29(2):87-90. PubMed ID: 26872802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.